Retour sur lavenir.net
   ACKERMANS V.HAAREN 266.600 € (-2,70 %)     AEDIFICA 69.150 € (-1,36 %)     CMB.TECH 13.620 € (+2,41 %)     LOTUS BAKERIES 11 240.000 € (-1,40 %)     TINC 11.180 € (-0,71 %)     HYLORIS 4.410 € (+0,68 %)     RECTICEL 11.040 € (-2,99 %)     FLUXYS BELGIUM D 19.500 € (-0,51 %)     BANQUP GROUP 2.020 € (-3,81 %)     TITAN S.A. 49.460 € (-3,21 %)     ASCENCIO 51.700 € (-0,19 %)     VAN DE VELDE 29.900 € (-0,33 %)     DEME GROUP 168.000 € (-2,78 %)     INCLUSIO SA/NV 16.600 € (-1,19 %)     PROXIMUS 5.870 € (+0,69 %)     AGFA-GEVAERT 0.418 € (-0,60 %)     ELIA GROUP 136.300 € (-0,94 %)     KINEPOLIS GROUP 35.650 € (-1,38 %)     MELEXIS 74.000 € (+1,79 %)     XIOR 27.100 € (-0,55 %)     IBA 16.500 € (-2,48 %)     FAGRON 23.800 € (-1,04 %)     TESSENDERLO 19.800 € (-2,22 %)     VGP 81.800 € (-4,88 %)     DECEUNINCK 2.230 € (-1,55 %)     GIMV 44.650 € (-1,65 %)     RETAIL ESTATES 68.000 € (-2,30 %)     CAMPINE 214.000 € (+1,90 %)     UMICORE 19.760 € (-2,95 %)     TUBIZE-FIN 214.800 € (-0,74 %)     SOLVAC NOM(RETAIL) 73.500 € (+0,68 %)     SYENSQO 64.750 € (-2,63 %)     NYXOAH 1.508 € (+3,86 %)     AGEAS 70.900 € (+0,35 %)     WERELDHAVE BELGIUM 52.800 € (-1,12 %)     AB INBEV 69.720 € (-1,22 %)     VASTNED 29.350 € (-1,01 %)     AZELIS GROUP 9.950 € (+0,66 %)     COLRUYT 36.520 € (-0,65 %)     UCB 248.700 € (-2,01 %)     ACCENTIS 0.026 € (-1,89 %)     BQUE NAT. BELGIQUE 370.000 € (+2,21 %)     ARGENX SE 799.800 € (-1,53 %)     MONTEA 66.000 € (-2,22 %)     VIOHALCO 17.920 € (-5,68 %)     D'IETEREN GROUP 170.700 € (-3,99 %)     WDP 21.740 € (-2,25 %)     ECONOCOM GROUP 1.430 € (-1,72 %)     KBC ANCORA 81.800 € (-2,15 %)     BARCO 8.385 € (-1,58 %)     ROULARTA 12.900 € (-0,77 %)     ENERGYVISION 14.820 € (-0,27 %)     HOME INVEST BE. 18.940 € (-2,17 %)     BPOST 1.600 € (-2,68 %)     SOLVAY 25.900 € (-1,22 %)     ONTEX GROUP 2.300 € (-3,36 %)     BIOTALYS 3.035 € (+0,50 %)     GBL 78.100 € (-0,45 %)     ONWARD MEDICAL 2.445 € (-3,36 %)     SOFINA 224.400 € (-1,67 %)  
   TIKEHAU CAPITAL 16.880 € (-1,29 %)     SCHNEIDER ELECTRIC 263.800 € (-1,57 %)     SOCIETE GENERALE 71.300 € (-5,79 %)     ABN AMRO BANK N.V. 37.820 € (-1,74 %)     ASML HOLDING 1 529.000 € (+1,27 %)     STMICROELECTRONICS 58.490 € (+0,33 %)     PERNOD RICARD 64.160 € (-2,61 %)     SBM OFFSHORE 32.780 € (+4,20 %)     ORANGE 15.950 € (+0,19 %)     UBISOFT ENTERTAIN 5.850 € (-2,76 %)     VEOLIA ENVIRON. 36.700 € (-0,84 %)     2CRSI 32.420 € (-10,93 %)     SODEXO 54.100 € (+1,31 %)     AIR FRANCE -KLM 12.840 € (-6,55 %)     METAVISIO 0.001 € (0,00 %)     LEGRAND 142.150 € (+0,28 %)     CEGEDIM 10.500 € (+0,19 %)     ABIVAX 122.100 € (-3,71 %)     THALES 233.700 € (-1,64 %)     WOLTERS KLUWER 59.020 € (-1,93 %)     DASSAULT AVIATION 297.200 € (-2,17 %)     TOTALENERGIES 69.350 € (+2,32 %)     ATOS GROUP 32.800 € (-4,65 %)     BENETEAU 5.990 € (-2,44 %)     LVMH 484.900 € (-2,20 %)     CREDIT AGRICOLE 17.200 € (-2,27 %)     NN GROUP 76.240 € (+0,18 %)     SHELL PLC 36.150 € (+2,48 %)     VIVORYON 1.260 € (+7,69 %)     S.E.B. 48.520 € (-0,98 %)     SOPRA STERIA GROUP 148.900 € (-2,04 %)     KERLINK 1.260 € (-3,08 %)     WORLDLINE 10.054 € (-3,35 %)     ACCOR 48.190 € (-3,50 %)     HYDROGEN REFUELING 1.410 € (+6,17 %)     VALEO 12.180 € (-5,54 %)     UNILEVER 54.450 € (-1,07 %)     HAFFNER ENERGY 0.241 € (+4,57 %)     FORVIA 8.760 € (-3,01 %)     MICHELIN 34.220 € (-2,37 %)     AALBERTS NV 38.840 € (-1,22 %)     SES 7.875 € (+1,42 %)     OCI 4.088 € (+0,20 %)     L'OREAL 380.750 € (-1,96 %)     TKH GROUP 42.180 € (-1,13 %)     TRIGANO 142.300 € (-2,06 %)     JCDECAUX 20.660 € (-0,19 %)     EIFFAGE 119.050 € (-4,11 %)     AHOLD DEL 36.060 € (-0,74 %)     KLEPIERRE 35.560 € (-1,17 %)     PLANISWARE 20.450 € (-3,08 %)     FUGRO 9.835 € (+3,69 %)     AIR LIQUIDE 173.680 € (-2,53 %)     ASM INTERNATIONAL 889.800 € (-0,76 %)     ARCELORMITTAL SA 53.600 € (-4,49 %)     EXOSENS 59.300 € (-0,17 %)     ARCADIS 33.980 € (-0,35 %)     CVC CAPITAL 13.050 € (-2,68 %)     VALERIO TX 0.455 € (-1,09 %)     PROSUS 40.395 € (+2,77 %)  
News Réglementées
06/04/2023 13:25

Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc

The Vanguard Group, Inc. ( irsh)
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc

06-Apr-2023 / 12:25 GMT/BST


Ap27

 

FORM 8.3

 

IRISH TAKEOVER PANEL

 

OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER

RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1. KEY INFORMATION

 

  1.         Full name of discloser

The Vanguard Group, Inc.

  1.         Owner or controller of interests and short positions disclosed, if different from 1(a)

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 

  1.         Name of offeror/offeree in relation to whose relevant securities this form relates

Use a separate form for each offeror/offeree

Horizon Therapeutics plc

  1.         If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1)

 

  1.         Date position held/dealing undertaken

For an opening position disclosure, state the latest practicable date prior to the disclosure

04 April 2023

  1.           In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

N/A

 

2. INTERESTS AND SHORT POSITIONS

 

If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.

 

Ap28

 

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

(Note 2)

 

Class of relevant security
(Note 3)

US$0.0001 ordinary shares

 

Interests

Short positions

Number

%

Number

%

  1. Relevant securities owned and/or controlled

21,559,169

9.42%

 

 

  1. Cash-settled derivatives

 

 

 

 

  1. Stock-settled derivatives (including options) and agreements to purchase/ sell

 

 

 

 

Total

21,559,169

9.42%

 

 

 

All interests and all short positions should be disclosed.

 

Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit
(Note 5)

US$0.0001 ordinary shares

Purchase

10,755

108.35 USD

US$0.0001 ordinary shares

Sale

7,814

108.35 USD

 

 

 

Ap29

 

(b) Cash-settled derivative transactions

 

Class of
relevant
security

Product
description
e.g. CFD

Nature of dealing
e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position

Number of
reference
securities
(Note 6)

Price
per unit
(Note 5)

 

 

 

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of
relevant
security

Product
description e.g. call
option

Writing, purchasing, selling, varying
etc.

Number
of
securities
to which
option
relates
(Note 6)

Exercise
price per
unit

Type
e.g.
American,
European
etc.

Expiry
date

Option
money
paid/
received per unit

 

 

 

 

 

 

 

 

 

(ii) Exercise

 

Class of
relevant
security

Product
description
e.g. call
option

Exercising/
exercised
against

Number of
securities

Exercise
price per
unit
(Note 5)

  

 

 

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 3)

 

Class of
relevant
security

Nature of dealing
e.g. subscription,
conversion, exercise

Details

Price per unit (if
applicable)
(Note 5)

 Not Applicable

 

 

 

 

Ap30

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer.

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 none

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 none

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière